QuantaMatrix Inc. (KOSDAQ:317690)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,900.00
-110.00 (-2.74%)
At close: Apr 28, 2026
1.96%
Market Cap 78.53B
Revenue (ttm) 3.69B
Net Income (ttm) -19.46B
Shares Out 20.14M
EPS (ttm) -1,052.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 86,940
Average Volume 93,223
Open 3,970.00
Previous Close 4,010.00
Day's Range 3,880.00 - 3,995.00
52-Week Range 2,920.00 - 6,550.00
Beta 0.08
RSI 53.89
Earnings Date Apr 3, 2026

About QuantaMatrix

QuantaMatrix Inc. operates as an in-vitro diagnostics company in South Korea. Its products include dRAST, a direct and rapid antimicrobial susceptibility test for treating sepsis that provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture; QDST, a rapid phenotypic drug susceptibility testing system for tuberculosis; QPLEX Alz plus assay, an early diagnosis kit for Alzheimer's disease; and Quanti9 and QuantiGal, a prognostic prediction kit for cardiovascular diseases. QuantaMatrix Inc. was founded i... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 317690
Full Company Profile

Financial Performance

In 2025, QuantaMatrix's revenue was 3.69 billion, an increase of 47.70% compared to the previous year's 2.50 billion. Losses were -19.46 billion, -3.51% less than in 2024.

Financial Statements

News

There is no news available yet.